RAC 5.59% $1.70 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-163

  1. 1,515 Posts.
    lightbulb Created with Sketch. 378
    It really makes it easy to visualise doesn’t it, it sadly I can’t take credit for making it.
    Basically RAC all stage 2 in the preclinical & clinical early stages.

    Just to get Bisantrene to this stage is indeed fortunate especially after being shelved/abandoned at one stage before RAC picked it back up. Thankfully due to previous trials & safety data in humans RAC have a massive headstart & have saved 100s of millions of dollars.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.70
Change
0.090(5.59%)
Mkt cap ! $289.5M
Open High Low Value Volume
$1.60 $1.76 $1.59 $142.7K 84.97K

Buyers (Bids)

No. Vol. Price($)
2 17175 $1.70
 

Sellers (Offers)

Price($) Vol. No.
$1.77 6060 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.